Searched for
TARO PHARMA
Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...- Sun's strong gravity helps India Inc's pullSun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Sun Pharma jumps 4% on solid Taro Pharma resultsTaro Pharma reported a 422 per cent year-on-year (YoY) jump in its net profit for the third quarter.
- Sun Pharma drops plan to buy out Taro’s minority shareholdersSun Pharma had acquired majority stake (66%) in the Israeli generic firm Taro Pharma in 2007 for $450 million, but got control of the compa...
- Sun Pharma under scanner for under-reporting Taro's Q3 resultsA minority shareholder of Taro Pharma has alleged that the company's financial results have been under-reported by its Indian promoter, Sun...
- Taro Pharma shareholder rejects Sun Pharma's revised offerA minority shareholder of Taro Pharma on Monday rejected Sun Pharma's sweetened offer price of $39.5 a share for a buyout, signalling furth...
- Taro Pharma panel turns down Sun Pharma's open offer priceSun Pharma, which holds about 67% stake in Taro, had made an open offer of $24.50 a share last year for the remaining stake.
- Guardian Point asks Sun Pharma to up Taro Pharma offerGuardian Point Capital, one of the minority shareholders of Israeli firm Taro Pharma, has asked Sun Pharma to revise $24.50 share price off...
- Sun Pharma says won't revise taro offer priceMumbai-based Sun Pharma will not revise its offer price to minority shareholders of Isreali drug maker Taro pharma, a company official said.
- Pharma major, Sun, back on growth trackAfter facing a regulatory clampdown by the US FDA in 2009, Caraco has had its manufacturing suspended. It now sells distributed products.
- Sun Pharma ups stake in Taro to 48.7%, Shanghvi to be ChairmanSun Pharma took an important step towards nearly doubling its US turnover by winning a bitter three-year battle for control of Israel's Tar...
- Taro integration worries weigh on Sun Pharma investorsThe latest verdict of the Israeli Supreme Court will enable Sun Pharma to increase its stake in Taro to around 53 per cent.
- Glenmark enters into licence, supply pact with Taro PharmaPharma firm Glenmark Pharmaceuticals on Thursday said that it has entered into a licencing agreement with US-based Taro Pharmaceuticals Inc...
- Taro to shut down Irish plant to control lossesIsraeli drugmaker Taro Pharma on Thursday said it is closing its Irish manufacturing plant to stem further losses, inviting allegations of ...
- Sun shines over Taro: Israeli court clears decks for takeoverSun Pharmaceuticals has won the first round in the legal battle for Taro Pharma, with the Tel-Aviv district court asking promoters of the I...
- Taro's bid will be exacting: AnalystsSun Pharmaceuticals’ decision to launch a hostile bid for Israel’s Taro Pharma may consume time as well as money as both cos are involved i...
- Taro calls off deal with Sun PharmaSun Pharma, India's largest pharma company by market capitalisation, has failed to clinch the deal for Israeli major Taro Pharma.
- Sun tightens grip on Taro, ups stakeSun Pharmaceuticals has consolidated its position in Taro Pharma, the Israeli company it agreed to buy for about $454 million in June, even...
Load More
